High Prevalence of Latent Tuberculosis Infection in Dialysis Patients Using the Interferon-γ Release Assay and Tuberculin Skin Test

QuantiFERON‐TB Gold In‐Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single‐center study in an area endemic for TB

“…The positive TST results in our study patients with hepatic failure were lower (15.9%) in comparison with reported positive TST in liver recipients in Canada (24.2%) and Italy (40%) (2,26). The positive TST in renal transplant candidates in our study was 21.9% in comparison with 62.5% of kidney recipients in Taiwan (7,8) and 23.6% in Tabriz, Iran (27). Lower rate of positive TST in our patients could be explained by different demographic characteristics of study patients, different cutoff point for positive TST (>10 mm vs. 5 mm), and more severe organ damage in our patients.…”

Undiagnosed diabetes mellitus and tuberculosis infection: A population‐based, observational study from eastern China

“…In addition, almost one million individuals develop tuberculosis every year in China . Despite this alarming situation, few studies have explored the relationship between diabetes and tuberculosis‐related outcomes in China . We conducted a population‐based cohort study in eastern China to further understand the relationship between diabetes and tuberculosis infection.…”

“…11,12 Despite this alarming situation, few studies have explored the relationship between diabetes and tuberculosis-related outcomes in China. [13][14][15][16][17] We conducted a population-based cohort study in eastern China to further understand the relationship between diabetes and tuberculosis infection. We examined whether diabetics were at increased odds of tuberculosis infection using both the QuantiFERON-TB (QFT) Gold In-Tube and tuberculin skin tests (TST) and further investigated whether undiagnosed diabetics were at differential infection risk.…”

Scaling up of latent tuberculosis infection treatment for close contacts of tuberculosis in Taiwan

“…However, IGRAs could probably offer higher sensitivity than the TST in elderly or immunocompromised populations with waning or poor T cell response. 7,8 Isoniazid monotherapy for LTBI treatment is still the standard drug of choice for LTBI treatment. A recently introduced alternative regimen for LTBI is 12 doses of once weekly rifapentine (900 mg) plus isoniazid (900 mg).…”